These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 11222205)
1. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. Takayasu K; Muramatsu Y; Maeda T; Iwata R; Furukawa H; Muramatsu Y; Moriyama N; Okusaka T; Okada S; Ueno H AJR Am J Roentgenol; 2001 Mar; 176(3):681-8. PubMed ID: 11222205 [TBL] [Abstract][Full Text] [Related]
2. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. Takayasu K; Arii S; Matsuo N; Yoshikawa M; Ryu M; Takasaki K; Sato M; Yamanaka N; Shimamura Y; Ohto M AJR Am J Roentgenol; 2000 Sep; 175(3):699-704. PubMed ID: 10954453 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. Chung JW; Park JH; Han JK; Choi BI; Han MC AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547 [TBL] [Abstract][Full Text] [Related]
4. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session]. El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077 [TBL] [Abstract][Full Text] [Related]
5. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors. Park SH; Cho YK; Ahn YS; Park YO; Kim JK; Chung JW Korean J Radiol; 2007; 8(2):111-9. PubMed ID: 17420628 [TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for local tumor recurrence after segmental transarterial chemoembolization for hepatocellular carcinoma: the importance of tumor located in the segmental border zone. Cho YK; Chung JW; Ahn YS; Park YO; Kim JK; Byun JH Korean J Radiol; 2006; 7(4):267-74. PubMed ID: 17143030 [TBL] [Abstract][Full Text] [Related]
9. Computed tomographic-guided radiofrequency ablation of recurrent or residual hepatocellular carcinomas around retained iodized oil after transarterial chemoembolization. Koh YH; Choi JI; Kim HB; Kim MJ Korean J Radiol; 2013; 14(5):733-42. PubMed ID: 24043966 [TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Kim P; Prapong W; Sze DY; So SK; Razavi MK Tech Vasc Interv Radiol; 2002 Sep; 5(3):127-31. PubMed ID: 12524643 [TBL] [Abstract][Full Text] [Related]
11. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study]. Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217 [TBL] [Abstract][Full Text] [Related]
12. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777 [TBL] [Abstract][Full Text] [Related]
13. Local recurrence after chemoembolization of hepatocellular carcinoma: uptake of gadoxetic acid as a new prognostic factor. Ishimaru H; Nakashima K; Sakugawa T; Sakamoto A; Matsuoka Y; Ashizawa K; Uetani M AJR Am J Roentgenol; 2014 Apr; 202(4):744-51. PubMed ID: 24660701 [TBL] [Abstract][Full Text] [Related]
14. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M; AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Choi BI; Kim HC; Han JK; Park JH; Kim YI; Kim ST; Lee HS; Kim CY; Han MC Radiology; 1992 Mar; 182(3):709-13. PubMed ID: 1311116 [TBL] [Abstract][Full Text] [Related]
16. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y; Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma supplied by the right lumbar artery. Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Sugimori N; Igarashi S; Nakashima Y; Matsui O Cardiovasc Intervent Radiol; 2010 Feb; 33(1):53-60. PubMed ID: 19484293 [TBL] [Abstract][Full Text] [Related]
18. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder. Clouse ME; Stokes KR; Kruskal JB; Perry LJ; Stuart KE; Nasser IA J Vasc Interv Radiol; 1993; 4(6):717-25. PubMed ID: 7506597 [TBL] [Abstract][Full Text] [Related]
19. Caudate lobe hepatocellular carcinoma treated with selective chemoembolization. Kim HC; Chung JW; Jae HJ; Yoon JH; Lee JH; Kim YJ; Lee HS; Yoon CJ; Park JH Radiology; 2010 Oct; 257(1):278-87. PubMed ID: 20697120 [TBL] [Abstract][Full Text] [Related]
20. Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. Miyayama S; Matsui O; Yamashiro M; Ryu Y; Kaito K; Ozaki K; Takeda T; Yoneda N; Notsumata K; Toya D; Tanaka N; Mitsui T J Vasc Interv Radiol; 2007 Mar; 18(3):365-76. PubMed ID: 17377182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]